Vertex Pharmaceuticals Inc Development Agreements
10 Contracts & Agreements
- Amendment No. 1 to Amended and Restated Joint Development and Commercialization Agreement, dated December 23, 3023, between Vertex Pharmaceuticals Incorporated, Vertex... (Filed With SEC on February 15, 2024)
- Amendment No. 7 to Research, Development and Commercialization Agreement, dated October 13, 2016, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)
- Amendment No. 5 to Research, Development and Commercialization Agreement, effective as of April 1, 2011, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)
- Amendment No. 1 to Research, Development and Commercialization Agreement, dated as of January 6, 2006, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation... (Filed With SEC on November 3, 2021)
- Research, Development and Commercialization Agreement, dated as of May 24, 2004, between Vertex Pharmaceuticals Incorporated and Cystic Fibrosis Foundation Therapeutics... (Filed With SEC on November 3, 2021)
- Amended and Restated Joint Development and Commercialization Agreement, dated April 16, 2021, between Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited... (Filed With SEC on July 30, 2021)
- Joint Development and Commercialization Agreement, dated December 12, 2017, between Vertex Pharmaceuticals Incorporated, Vertex Pharmaceuticals (Europe) Limited and CRISPR... (Filed With SEC on February 11, 2021)
- Confidential Treatment Requested Confidential portions of this document have been redacted and have been separately filed with the Commission AMENDMENT NO. 5 to RESEARCH,... (Filed With SEC on August 9, 2011)
- Confidential Treatment Requested Confidential portions of this document have been redacted and have been separately filed with the Commission RESEARCH, DEVELOPMENT AND... (Filed With SEC on August 9, 2011)
- Confidential TreatmentRequested. Confidential portions of thisdocument have been redacted and have been separately filed with the Commission AMENDMENT NO. 2 to RESEARCH,... (Filed With SEC on May 10, 2006)
